286 related articles for article (PubMed ID: 25994830)
21. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
[TBL] [Abstract][Full Text] [Related]
22. Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.
de Boer RA; Pokharel S; Flesch M; van Kampen DA; Suurmeijer AJ; Boomsma F; van Gilst WH; van Veldhuisen DJ; Pinto YM
J Mol Med (Berl); 2004 Oct; 82(10):678-87. PubMed ID: 15322702
[TBL] [Abstract][Full Text] [Related]
23. Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice.
Chen P; Yang F; Wang W; Li X; Liu D; Zhang Y; Yin G; Lv F; Guo Z; Mehta JL; Wang X
J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):179-188. PubMed ID: 32686479
[TBL] [Abstract][Full Text] [Related]
24. [Alteration of signal transduction-associated gene expression in rat cardiac fibroblasts induced by blocking angiotensin II receptors].
Jiang XY; Gao GD; Wang XF; Lin YX; Wang YW; Yang YB
Sheng Li Xue Bao; 2006 Dec; 58(6):556-66. PubMed ID: 17173190
[TBL] [Abstract][Full Text] [Related]
25. Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes.
Heymes C; Silvestre JS; Llorens-Cortes C; Chevalier B; Marotte F; Levy BI; Swynghedauw B; Samuel JL
Endocrinology; 1998 May; 139(5):2579-87. PubMed ID: 9564874
[TBL] [Abstract][Full Text] [Related]
26. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
27. Effect of angiotensin II on rhythmic per2 expression in the suprachiasmatic nucleus and heart and daily rhythm of activity in Wistar rats.
Herichová I; Šoltésová D; Szántóová K; Mravec B; Neupauerová D; Veselá A; Zeman M
Regul Pept; 2013 Sep; 186():49-56. PubMed ID: 23850797
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
29. CD44 Deficiency in Mice Protects the Heart Against Angiotensin Ii-Induced Cardiac Fibrosis.
Yang LW; Qin DZ; James E; McKallip RJ; Wang NP; Zhang WW; Zheng RH; Han QH; Zhao ZQ
Shock; 2019 Mar; 51(3):372-380. PubMed ID: 29470359
[TBL] [Abstract][Full Text] [Related]
30. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
Brilla CG; Scheer C; Rupp H
J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression.
Tsutsumi Y; Matsubara H; Ohkubo N; Mori Y; Nozawa Y; Murasawa S; Kijima K; Maruyama K; Masaki H; Moriguchi Y; Shibasaki Y; Kamihata H; Inada M; Iwasaka T
Circ Res; 1998 Nov; 83(10):1035-46. PubMed ID: 9815151
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases.
Ferreira AJ; Shenoy V; Qi Y; Fraga-Silva RA; Santos RA; Katovich MJ; Raizada MK
Exp Physiol; 2011 Mar; 96(3):287-94. PubMed ID: 21148624
[TBL] [Abstract][Full Text] [Related]
33. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries.
Brassard P; Amiri F; Schiffrin EL
Hypertension; 2005 Sep; 46(3):598-606. PubMed ID: 16043661
[TBL] [Abstract][Full Text] [Related]
34. Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme.
Abouelkheir M; El-Metwally TH
Eur J Pharmacol; 2019 Nov; 862():172638. PubMed ID: 31491403
[TBL] [Abstract][Full Text] [Related]
35. Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis.
Gaspari T; Brdar M; Lee HW; Spizzo I; Hu Y; Widdop RE; Simpson RW; Dear AE
Diab Vasc Dis Res; 2016 Jan; 13(1):56-68. PubMed ID: 26408644
[TBL] [Abstract][Full Text] [Related]
36. Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats.
Romaní-Pérez M; Outeiriño-Iglesias V; Moya CM; Santisteban P; González-Matías LC; Vigo E; Mallo F
Endocrinology; 2015 Oct; 156(10):3559-69. PubMed ID: 26196539
[TBL] [Abstract][Full Text] [Related]
37. Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy.
Zheng RH; Zhang WW; Ji YN; Bai XJ; Yan CP; Wang J; Bai F; Zhao ZQ
Eur J Pharmacol; 2020 Sep; 883():173318. PubMed ID: 32621911
[TBL] [Abstract][Full Text] [Related]
38. Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.
Zhong J; Guo D; Chen CB; Wang W; Schuster M; Loibner H; Penninger JM; Scholey JW; Kassiri Z; Oudit GY
Hypertension; 2011 Feb; 57(2):314-22. PubMed ID: 21189404
[TBL] [Abstract][Full Text] [Related]
39. Transitory reduction in angiotensin AT2 receptor expression levels in postinfarct remodelling in rat myocardium.
Lax CJ; Domenighetti AA; Pavia JM; Di Nicolantonio R; Curl CL; Morris MJ; Delbridge LM
Clin Exp Pharmacol Physiol; 2004 Aug; 31(8):512-7. PubMed ID: 15298543
[TBL] [Abstract][Full Text] [Related]
40. Pouch tissue and angiotensin peptide generation.
Katwa LC; Sun Y; Campbell SE; Tyagi SC; Dhalla AK; Kandala JC; Weber KT
J Mol Cell Cardiol; 1998 Jul; 30(7):1401-13. PubMed ID: 9710808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
